blog post."Apparently the vaccine is generating the kind of antibody and T-cell (killer cell) response that the researchers would hope to see."AstraZeneca Plc climbed 5% in London after ITV.com reported that The Lancet medical journal is due to release positive news on the vaccine the company is developing with University of Oxford researchers.He tweeted: "Positive news is coming on Oxford Covid-19 vaccine.
The vaccine is generating the kind of antibody and T-cell (killer cell) response that the researchers would hope to see, I understand.